Generic placeholder image

Current Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 0929-8673
ISSN (Online): 1875-533X

Review Article

Lipoprotein (a) Management: Lifestyle and Hormones

Author(s): Antonio Garcia-Rios, Ana Leon-Acuna, Jose Lopez-Miranda and Pablo Perez-Martinez*

Volume 24 , Issue 10 , 2017

Page: [979 - 988] Pages: 10

DOI: 10.2174/0929867324666170124144427

Price: $65

Abstract

Cardiovascular disease (CVD) continues to be the first cause of mortality in developed countries. Moreover, far from diminishing, the cardiovascular risk factors leading towards the development of CVD are on the rise. Therefore, the preventive and therapeutic management which is currently in place is clearly not enough to stop this pandemic. In this context, a major resurgence in interest in lipoprotein (a) [Lp(a)] has occurred in light of its association with CVD. This series aims to review the basic and clinical aspects of Lp(a) biology. Specifically, the present review considers the current situation regarding the influence of lifestyle, hormones and other physiological or pathological conditions on Lp(a) plasma concentrations which might mitigate the harmful effects of this lipoprotein.

Keywords: Lipoprotein (a), cardiovascular disease, lifestyle, hormones, diet, exercise.


Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy